End Brain Cancer is made and published by VOBO, LLC. AppBrain is an independent app data site and isn't affiliated with VOBO, LLC. The app name, icon, screenshots and description belong to VOBO, LLC and are shown as published on the App Store.
AppBrain's verdict
- Rating on App Store
- 5.00
- 1 ratings
- Last updated
- July 1, 2025
- Size
- 84.1 MB
It doesn't have enough ratings yet to judge what users think.
User feedback
Ratings and reviews on the App StoreComments on End Brain Cancer for iOS
We don't have enough comments to show example comments. Please check back later.
Store listing
By VOBO, LLC, from the App StoreDescription by VOBO, LLC Written by the developer, not by AppBrain. Click to read.
Specific channels of information are:
Clinical Trials – large sponsored AND investigator sponsored US opportunities
Patient Resources – our created content as well as applicable content from other sources
Research – latest and greatest peer reviewed articles and information as it becomes available
Meetings & Events – Webinars, Events, Online and/or Virtual events applicable to the target community
In Other News – interesting articles that may be beyond the brain space or outside of peer reviewed publication but may be promising or future looking for the target community
EBCI in the News – News and happenings directly involving EBCI and partners
Call to Action – Advocacy opportunities, templates for support of policy changes, suggestions on communications to legislators, etc
Donate of Support – Links for donations or to volunteer, etc
Low Grade Glioma – a channel dedicated to information regarding the low-grade glioma population
PCNSL – a channel dedicated to the rare disease Primary Central Nervous System Lymphoma (PCNSL).
Caregiver Resources – a dedicated channel to resources that would be useful to caregivers
Bookshop – a link to the virtual bookshop where we have identified several useful book resources. All proceeds from sales will benefit EBCI.
You can also subscribe to various “Groups” in order to receive notifications when there is new content specific to your interests, such as Clinical Trials, events and meetings, latest news, among other topics. This app has the ability to survey the population, and to send push notices, post videos and audio files.
Safety and technology
Found in the app by AppBrain- Price
- Free
- App size
- 84.1 MB
- Content rating
- High
Technologies used by End Brain Cancer
Releases
Updates seen on the App Store- Version
- 2.10.4
- Launched
- November 2022
No changelog data
Alternatives
Similar apps and more from VOBO, LLCRankings
App Store top chartsApp Store Rankings for End Brain Cancer
About the app and developer
About End Brain Cancer
End Brain Cancer is a medical app developed by VOBO, LLC.
What is the rating of End Brain Cancer?
End Brain Cancer is rated 5.00 out of 5 stars, based on one rating ratings.
Is End Brain Cancer free?
End Brain Cancer is free. The app size is 84.08 MB. The latest version available is 2.10.4. The last update was on July 1, 2025.
What are the requirements for End Brain Cancer?
The app has a content rating of High Maturity. The app has been available on the App Store since November 2022.
Developer information for VOBO, LLC
Address:
Frequently asked questions about End Brain Cancer
Is End Brain Cancer free?
Yes. End Brain Cancer is free on the App Store.
Is End Brain Cancer still available?
Yes. End Brain Cancer is on the App Store, and the last update we saw was on July 1, 2025.
How large is End Brain Cancer?
End Brain Cancer is 84.08 MB.
Is End Brain Cancer suitable for children?
App Store gives End Brain Cancer a high maturity rating. It is meant for adults.
How do people rate End Brain Cancer?
End Brain Cancer has one rating of 5.00 stars on the App Store.
Who made End Brain Cancer?
End Brain Cancer was developed by VOBO, LLC. It is listed in the medical category on the App Store.
What are the best alternatives to End Brain Cancer?
People looking at End Brain Cancer also look at these medical apps: Excel Wellness, COH: Connecting Care, MD Fitness, ESSFN 2025, Cancer Pharmacology Manual.